SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksJames Halstead Regulatory News (JHD)

Share Price Information for James Halstead (JHD)

Share Price is delayed by 15 minutes
Get Live Data
128.80    4.60 (3.70%)
Bid:
128.20
Ask:
129.60
Spread: 1.40 (1.092%)
Market Cap: £536.34m
JHD Live PriceLast checked at - London Stock Exchange

Intraday James Halstead Share Chart

Pre-Close Trading Statement

25 Jul 2018 07:00

RNS Number : 6057V
James Halstead PLC
25 July 2018
 

25 July 2018

 

 

Pre-Close Trading Statement

 

 

James Halstead plc, the commercial flooring manufacturer and distributor, is providing the following trading update ahead of its final results for the year ended 30 June 2018.

 

We are pleased to report that sales for the year were ahead of the comparative year. This represents a creditable performance in still difficult trading conditions. It is particularly pleasing to report that our UK turnover is 3% ahead of the prior year in a market that seems to be quite robust despite the well reported spending cuts and high street retailer issues.

 

In the Chairman's interim statement, announced on 29 March 2018, it was noted that adverse price pressure on raw materials was holding back the benefits of export currency gains. This continued in the second half year but was ameliorated by increased sales. The Chairman, in that statement, noted that a German competitor had entered administration and at that time we decided to undertake our largest ever re-vamp of our homogenous flooring ranges with the launch of "Palettone."

 

Palettone is a premium homogenous sheet vinyl collection, launched in May 2018. It is the largest new product development by any manufacturer in this core product area in many years. It offers a collection of 50 colours optimised for our global market and is presented in a unique, innovative sample package with full customer support from specification to installation. The feedback we have received on the collection since launch has been exceptional.

 

The costs of development trials, sampling, marketing material and related costs have been around £2 million and the product has just been launched into the global market place. The timescale that our production and marketing staff worked to was ambitious and we are delighted with the successful launch.

 

In line with best practice, we shall expense these costs rather than amortise or construct an adjustment to "underlying" earnings.

 

Consequently we are pleased to anticipate, once again, reporting record turnover and expect profits for the year to 30 June 2018 will be in line with last year.

 

 

This announcement contains inside information for the purposes of Article 7 of EU Regulation 596/2014. 

 

 

Enquiries:

 

 

Mark Halstead, Chief Executive

 

Gordon Oliver, Finance Director

Telephone: 0161 767 2500

 

 

Nick Lyon - Hudson Sandler

Telephone: 020 7796 4133

 

 

Ben Thorne

Dominic Morley - Panmure Gordon

(Nominated advisor and broker)

 

Telephone: 020 7886 2500

 

Chris Hardie - Arden Partners

Telephone: 020 7614 5900

(Broker)

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TSTBZLFLVDFEBBX
Date   Source Headline
4th May 20185:09 pmRNSForm 8.5 (EPT/RI) - James Halstead PLC
4th May 201811:50 amRNSForm 8.5 (EPT/NON-RI)
4th May 201810:03 amRNSForm 8.3 - James Halstead
4th May 20188:52 amRNSForm 8.5 (EPT/RI) - James Halstead PLC
3rd May 20181:47 pmRNSForm 8.5 (EPT/RI) - James Halstead PLC
3rd May 201812:04 pmRNSForm 8.3 - James Halstead
3rd May 201811:57 amRNSForm 8.3 - James Halstead
3rd May 201811:50 amRNSForm 8.5 (EPT/NON-RI)
3rd May 20189:16 amRNSForm 8.5 (EPT/RI) - James Halstead PLC
2nd May 20183:57 pmRNSStatement re Airea plc
2nd May 201811:50 amRNSForm 8.5 (EPT/NON-RI)
2nd May 20189:00 amRNSForm 8.5 (EPT/RI) - James Halstead PLC
1st May 201811:50 amRNSForm 8.5 (EPT/NON-RI)
1st May 20189:51 amRNSForm 8.3 - James Halstead
1st May 20188:19 amRNSForm 8.5 (EPT/RI) - James Halstead PLC
30th Apr 20184:31 pmRNSMavis Warren family - Form 8.3 - James Halstead
30th Apr 20184:26 pmRNSEdith Hayhurst - Form 8.3 - James Halstead plc
30th Apr 20184:21 pmRNSExors Audrey Halstead - Form 8.3 - James Halstead
30th Apr 201811:50 amRNSForm 8.5 (EPT/NON-RI)
30th Apr 20189:58 amRNSForm 8.5 (EPT/RI) - James Halstead
27th Apr 20181:53 pmRNSPanmure Gordon - Form 8.5 (EPT/RI) James Halstead
27th Apr 201811:50 amRNSForm 8.5 (EPT/NON-RI)
27th Apr 201810:43 amRNSForm 8.3 - James Halstead
26th Apr 201812:54 pmRNSForm 8.5 (EPT/NON-RI)
24th Apr 201811:43 amRNSForm 8.3 - James Halstead
24th Apr 201811:21 amRNSForm 8.3 - James Halstead
24th Apr 201810:13 amRNSForm 8.3 - James Halstead
23rd Apr 20183:45 pmRNSForm 8.3 - James Halstead
18th Apr 20185:50 pmRNSAmendment - Form 8 (OPD) JAMES HALSTEAD PLC
18th Apr 20183:50 pmRNSAmendment - Form 8 (OPD) JAMES HALSTEAD PLC
18th Apr 20183:12 pmRNSAmendment - Form 8 (OPD) JAMES HALSTEAD PLC
18th Apr 20181:50 pmRNSForm 8 (OPD) JAMES HALSTEAD PLC
18th Apr 201811:50 amRNSForm 8.5 (EPT/NON-RI)
18th Apr 201811:30 amRNSForm 8.3 - James Halstead plc
16th Apr 201811:50 amRNSForm 8.5 (EPT/NON-RI)
13th Apr 201811:58 amRNSForm 8.3 - James Halstead PLC
13th Apr 201811:50 amRNSForm 8.5 (EPT/NON-RI)
12th Apr 201811:50 amRNSForm 8.5 (EPT/NON-RI)
11th Apr 201811:50 amRNSForm 8.5 (EPT/NON-RI)
10th Apr 201811:50 amRNSForm 8.5 (EPT/NON-RI)
9th Apr 201811:50 amRNSForm 8.5 (EPT/NON-RI)
9th Apr 201810:50 amRNSForm 8.3 - James Halstead PLC
6th Apr 20182:36 pmRNSForm 8.3 - James Halstead plc
6th Apr 201812:47 pmRNSForm 8.5 (EPT/NON-RI)
5th Apr 20187:00 amRNSStmnt re Share Price Movement - Replacement
4th Apr 20185:22 pmRNSStmnt re Share Price Movement
27th Mar 20187:00 amRNSInterim Results
20th Mar 201811:29 amRNSNotice of Results
29th Jan 20187:00 amRNSPre Close Trading Statement
1st Dec 20174:53 pmRNSResult of AGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.